Table 3.
Behavioral Outcomes
| Mean (SD) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Haloperidol | Placebo | |||||||||||
| −90 | −30 | +15 | +65 | +140 | +190 | −90 | −30 | +15 | +65 | +140 | +190 | ||
| PANSS | Positive | 7.78(1.09) | 7.89(1.16) | 7.78(1.09) | 7.78(1.09) | 9(1.5) | 7.56(1.13) | 7.4(0.52) | 7.4(0.52) | 7.4(0.5 2) | 7.5(0.71) | 10.3(0.95) | 7.8(0.91) |
| Negative | 6.78(1.3) | 6.44(1.01) | 6.22(0.44) | 6.33(0.71) | 8.63(1.85) | 6.4(0.72) | 6.4(0.7) | 6.2(0.42) | 6.1(0.31) | 6.2(0.42) | 7.7(1.16) | 6.3(0.67) | |
| General Psychopath ology | 15.67(1) | 15.67(0.87) | 16(0.71) | 15.56(0.73) | 18.11(1.69) | 15.67(0.71) | 15.3(0.48) | 15.5(0.71) | 15.6(0.7) | 15.5(0.85) | 18.9(3.03) | 15.6(0.7) | |
| Total | 30.22(2.91) | 30(2.29) | 30(1.58) | 29.67(1.32) | 35.88(2.52) | 29.67(2) | 29.1(1.1) | 29.1(0.99) | 29.1(0.88) | 29.2(1.03) | 36.9(3.51) | 29.7(1.42) | |
| CADSS | Clinician rated | 0 | 0 | 0.22(0.66) | 0 | 3.33(0.22) | 0.125(0.1) | 0(0) | 0.1(0.33) | 0.1(0.32) | 0.1(0.32) | 4.7(2.6) | 0.4(0.7) |
| Subjective | 0.22(0.67) | 0.5(1.67) | 0.67(1) | 0.2(0.67) | 3.7(3.15) | 1(2.12) | 0.1(0.31) | 0.2(0.42) | 0(0) | 0.2(0.63) | 6.7(5.05) | 1.9(2.4) | |
PANSS: Positive and Negative Syndrome Scale. CADSS: Clinician-Administered Dissociative States Scale.